Behavioral Predictors Of Substance-Use Initiation In Adolescents With And Without ADHD

J Gordon Millichap
2006 Pediatric Neurology Briefs  
COMMENT. At a mean daily dose of 24 mg/day, d-MPH-ER was significantly superior to placebo in the treatment of ADHD. The mean dose of d-MPH-ER found effective is equivalent to a 50 mg/day dose of racemic methylphenidate.
doi:10.15844/pedneurbriefs-20-7-8 fatcat:ecak7fitwjh6fb6flkqp6pvmrm